Literature DB >> 15071025

New approach for serological testing for leptospirosis by using detection of leptospira agglutination by flow cytometry light scatter analysis.

S Yitzhaki1, A Barnea, A Keysary, E Zahavy.   

Abstract

Leptospirosis is considered an important reemerging infectious disease worldwide. The standard and most widespread method for the diagnosis of leptospirosis is the microscopic agglutination test (MAT). This test is laborious and time-consuming, and the interpretation of the results is subjective. In the present work we describe an application of flow cytometry (FCM) as a tool for the serological diagnosis of leptospirosis. The analysis is based on the sensitivity of FCM to the size and shape of the bacteria analyzed by measurement of light scatter parameters: forward scatter (FSC) and side scatter (SSC). The addition of positive serum to an infecting leptospiral serovar results in a shift of the light scatter parameter to a different location with higher FSC and SSC values, indicating the formation of leptospiral aggregates. By using immunofluorescent staining, we have shown that the large particles formed are the agglutinated leptospires. Quantification of the agglutination process has been achieved by calculating an agglutination factor (Af), based on changes in the light scatter parameters measured by FCM. Af enables us to determine the specificity of the serological reaction of the patient serum with each leptospiral serovar. In this work, 27 serum samples from 18 leptospirosis patients were tested by both the MAT and the FCM techniques, in which each serum sample was tested against 13 serovars. Twenty-six human serum samples derived from patients with a variety of other defined illnesses were used as negative controls and enabled us to define the Af threshold value as < 9.3 for negative patients, while any value higher than that would be a positive result for leptospirosis. Compared to MAT, the FCM technique was found to be more specific and sensitive, especially in identifying the serogroup in the acute phase of the disease. The whole process was found to be rapid and took less than 1.5 h. Moreover, FCM analysis is objective and can be automated for the handling of large numbers of samples.

Entities:  

Mesh:

Year:  2004        PMID: 15071025      PMCID: PMC387560          DOI: 10.1128/JCM.42.4.1680-1685.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Leptospirosis worldwide, 1999.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1999-07-23

2.  A rapid macroscopicslide screening test for the serodiagnosis of leptospirosis.

Authors:  M M GALTON; D K POWERS; A D HALL; R G CORNELL
Journal:  Am J Vet Res       Date:  1958-04       Impact factor: 1.156

3.  Further evaluation of one-point microcapsule agglutination test for diagnosis of leptospirosis.

Authors:  J J Cui; G X Xiao; T Z Chen; G F Zhu; T Sato; M Seki; S Kobayashi; Y Arimitsu
Journal:  Epidemiol Infect       Date:  1991-06       Impact factor: 2.451

4.  Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1997-05-02

5.  International multicenter evaluation of the clinical utility of a dipstick assay for detection of Leptospira-specific immunoglobulin M antibodies in human serum specimens.

Authors:  H L Smits; Y V Ananyina; A Chereshsky; L Dancel; R F Lai-A-Fat; H D Chee; P N Levett; T Masuzawa; Y Yanagihara; M A Muthusethupathi; E J Sanders; D M Sasaki; H Domen; C Yersin; T Aye; S L Bragg; G C Gussenhoven; M G Goris; W J Terpstra; R A Hartskeerl
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

6.  Evaluation of the indirect hemagglutination assay for diagnosis of acute leptospirosis.

Authors:  P N Levett; C U Whittington
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

7.  Macroscopic agglutination test for rapid diagnosis of human leptospirosis.

Authors:  A P Brandão; E D Camargo; E D da Silva; M V Silva; R V Abrão
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

8.  Usefulness of serologic analysis as a predictor of the infecting serovar in patients with severe leptospirosis.

Authors:  Paul N Levett
Journal:  Clin Infect Dis       Date:  2003-01-29       Impact factor: 9.079

9.  Improved detection of bacteria by flow cytometry using a combination of antibody and viability markers.

Authors:  R G Clarke; A C Pinder
Journal:  J Appl Microbiol       Date:  1998-04       Impact factor: 3.772

10.  Evaluation of the immunofluorescent antibody test for the diagnosis of human leptospirosis.

Authors:  H Appassakij; K Silpapojakul; R Wansit; J Woodtayakorn
Journal:  Am J Trop Med Hyg       Date:  1995-04       Impact factor: 2.345

View more
  7 in total

1.  Application of fluorescent nanocrystals (q-dots) for the detection of pathogenic bacteria by flow-cytometry.

Authors:  Eran Zahavy; Vered Heleg-Shabtai; Yossi Zafrani; Daniele Marciano; Shmuel Yitzhaki
Journal:  J Fluoresc       Date:  2009-10-14       Impact factor: 2.217

2.  Validation of a microsphere immunoassay for serological leptospirosis diagnosis in human serum by comparison to the current gold standard.

Authors:  Sarah J Wynwood; Mary-Anne A Burns; Glenn C Graham; Steven L Weier; David B McKay; Scott B Craig
Journal:  PLoS Negl Trop Dis       Date:  2015-03-25

3.  Experimental Human Challenge Defines Distinct Pneumococcal Kinetic Profiles and Mucosal Responses between Colonized and Non-Colonized Adults.

Authors:  Elissavet Nikolaou; Simon P Jochems; Elena Mitsi; Sherin Pojar; Annie Blizard; Jesus Reiné; Carla Solórzano; Edessa Negera; Beatriz Carniel; Alessandra Soares-Schanoski; Victoria Connor; Hugh Adler; Seher R Zaidi; Caz Hales; Helen Hill; Angie Hyder-Wright; Stephen B Gordon; Jamie Rylance; Daniela M Ferreira
Journal:  mBio       Date:  2021-01-12       Impact factor: 7.867

Review 4.  Leptospiral Infection, Pathogenesis and Its Diagnosis-A Review.

Authors:  Antony V Samrot; Tan Chuan Sean; Karanam Sai Bhavya; Chamarthy Sai Sahithya; SaiPriya Chan-Drasekaran; Raji Palanisamy; Emilin Renitta Robinson; Suresh Kumar Subbiah; Pooi Ling Mok
Journal:  Pathogens       Date:  2021-02-01

5.  Corticosteroid in the treatment of moderate to severe thrombocytopenia due to leptospirosis.

Authors:  Shahriar Alian; Hasan Asghari; Narges Najafi; Alireza Davoudi; Jamshid Yazdani
Journal:  Iran Red Crescent Med J       Date:  2014-10-05       Impact factor: 0.611

6.  Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage.

Authors:  E Mitsi; A M Roche; J Reiné; T Zangari; J T Owugha; S H Pennington; J F Gritzfeld; A D Wright; A M Collins; S van Selm; M I de Jonge; S B Gordon; J N Weiser; D M Ferreira
Journal:  Mucosal Immunol       Date:  2016-08-31       Impact factor: 7.313

7.  The role of the Acanthamoeba castellanii Sir2-like protein in the growth and encystation of Acanthamoeba.

Authors:  So-Young Joo; Ja Moon Aung; Minsang Shin; Eun-Kyung Moon; Hyun-Hee Kong; Youn-Kyoung Goo; Dong-Il Chung; Yeonchul Hong
Journal:  Parasit Vectors       Date:  2020-07-22       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.